As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Isomorphic Labs, leveraging AI breakthroughs from DeepMind, is on the brink of human clinical trials for cancer drugs. With major pharma partnerships, the future of drug design looks promising!
A groundbreaking study reveals that a blood test can identify Alzheimer's patients at risk of rapid decline. Researchers highlight the importance of insulin resistance in accelerating cognitive impairment, opening doors for timely interventions.
Richard Schlueter, battling metastatic cancer, faces a desperate wait for experimental treatment as NIH staff cuts delay his therapy. His story sheds light on the critical impact of workforce reductions on patient care.
A new study indicates that a single dose of psilocybin can alleviate depression for up to five years, offering hope for those with major depressive disorder. This groundbreaking research highlights the potential of psychedelics in mental health treatment.
Recent research suggests that psilocybin, the active compound in magic mushrooms, may alleviate depressive episodes in bipolar II disorder, showing promise without triggering mania. The trial found significant improvements among participants, indicating a potential new treatment avenue.
A new phase 2 trial reveals that a single dose of psilocybin, combined with psychological support, significantly reduces depression in over half of cancer patients, lasting up to two years.
A new clinical trial shows that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients. With promising long-term results, this therapy offers hope for many.
